StonvexLoading…
StonvexStonvexStonvexCore line items from ECVT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $243.83M | $214.95M | $723.51M | $204.91M | $176.06M |
Operating Income | Not available | $12.54M | $64.89M | $28.27M | $15.78M |
Net Income | Not available | $4.31M | $-71.13M | $-79.25M | $5.99M |
EPS (Diluted) | $0.20 | $0.04 | $-0.61 | $-0.69 | $0.05 |
Total Assets | Not available | $1.25B | $1.26B | $1.73B | $1.80B |
Total Liabilities | Not available | $671.43M | $657.54M | $1.13B | $1.10B |
Cash & Equivalents | Not available | $162.55M | $197.19M | $81.98M | $69.60M |
Free Cash Flow OCF − CapEx | Not available | $2.80M | $69.89M | $46.95M | $-6.23M |
Shares Outstanding | Not available | 109.45M | 111.81M | 114.02M | 114.49M |